This notion is supported by the presence of IL-23, a cytokine that induces the IL-17-secreting phenotype in T CD8+ and that is produced by macrophages and dendritic cells located in MS lesions (Beriou et al. 2009). This evidence concerns the gene IL17A and myeloid sarcoma.